Current disease status-Recurrent cancer-Local recurrence - Page 4 of 7 Posts on Medivizor
Navigation Menu

Current disease status-Recurrent cancer-Local recurrence Posts on Medivizor

The effect of BAP1 protein in uveal melanoma

Posted by on Apr 16, 2015 in Melanoma | 0 comments

In a nutshell The authors aimed to determine the effects of BAP1 protein in uveal melanoma. Some background Uveal melanoma is a rare form of cancer that occurs in the eye. BAP1 protein is involved in cell development and growth in healthy cells. Research has shown that patients who lack the BAP1 protein have an increased risk of tumor...

Read More

Reviewing the cardicovascular effects of androgen deprivation therapy in prostate cancer

Reviewing the cardicovascular effects of androgen deprivation therapy in prostate cancer

Posted by on Jan 19, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether patients who received androgen deprivation therapy were more at risk of experiencing cardiovascular events. Some background Androgen deprivation therapy (ADT) is a hormone treatment that targets male sex hormones involved in prostate cancer development, such as testosterone, in early stage...

Read More

Health-related quality of life and sexual function in patients with rectal cancer

Health-related quality of life and sexual function in patients with rectal cancer

Posted by on Dec 8, 2014 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to compare health-related quality of life in healthy individuals and patients with rectal cancer. Some background Rectal cancer is one of the most common cancers worldwide. Beyond the cancer symptoms it is now well recognized that having cancer can also affect patients’ quality of life. A number of...

Read More

Is sunitinib plus transtuzumab safe and effective in patients with advanced breast cancer?

Is sunitinib plus transtuzumab safe and effective in patients with advanced breast cancer?

Posted by on Nov 27, 2014 in Breast cancer | 0 comments

In a nutshell This paper studied the safety and efficacy of sunitinib (Sutent) in combination with trastuzumab (Herceptin) in the treatment of advanced breast cancer.  Some background Trastuzumab is used to treat metastatic (cancer that has spread to other parts of the body) breast cancer that is human epidermal growth factor receptor 2...

Read More

Can we predict high-intensity focused ultrasound success before treatment?

Can we predict high-intensity focused ultrasound success before treatment?

Posted by on Nov 14, 2014 in Prostate cancer | 0 comments

In a nutshell This paper studied factors that might influence prostate-specific antigen (PSA) nadir levels following high-intensity ultrasound treatment in patients whose cancer has not spread beyond the prostate. Some background High-intensity focused ultrasound (HIFU) is a primary treatment in prostate cancer that targets and removes damaged or...

Read More

Is chemo after surgery necessary if no cancer is present in the lymph nodes?

Is chemo after surgery necessary if no cancer is present in the lymph nodes?

Posted by on Oct 8, 2014 in Colorectal cancer | 0 comments

In a nutshell This study evaluated whether patients whose cancer has not spread to the lymph nodes would benefit from additional chemotherapy following surgery. Some background Locally advanced rectal cancer means the cancer has spread from the rectum (the lowest part of the large bowel) into surrounding tissues and organs. The recommended...

Read More

MammaPrint genetic testing for prediction of long-term breast cancer outcomes

Posted by on Feb 24, 2014 in Breast cancer | 0 comments

In a nutshell This study investigated the accuracy of the 70-gene signature (MammaPrint) genomic profiling test in predicting metastasis and long-term outcomes among breast cancer patients. Some background Gene-expression signature tests, such as MammaPrint, were developed in order to assess the biological action, and therefore the aggressiveness,...

Read More

Prognostic significance of BRAF mutations

Prognostic significance of BRAF mutations

Posted by on Feb 11, 2014 in Melanoma | 0 comments

In a nutshell This study evaluated the effect of BRAF mutation on survival among early stage melanoma patients. Some background The B-raf protein, encoded by the BRAF gene, plays an important role in regulating cell growth and division. Mutations in the BRAF gene are implicated in approximately 40% of all melanoma cases. BRAF mutation is...

Read More

Timing of adjuvant chemotherapy after surgery

Timing of adjuvant chemotherapy after surgery

Posted by on Feb 9, 2014 in Breast cancer | 0 comments

In a nutshell This study examined whether the timing of adjuvant chemotherapy affects survival among women with breast cancer. Some background Surgical resection to remove all cancerous tissue is the standard of care for the treatment of breast cancer. After surgery, many patients also undergo adjuvant treatments (additional therapy following...

Read More

A non-invasive method of tumor removal

A non-invasive method of tumor removal

Posted by on Jan 11, 2014 in Breast cancer | 1 comment

In a nutshell This review examined the use of radiofrequency ablation as a treatment for breast cancer. Some background Surgical treatments for breast cancer have become less invasive over time, in hopes of preserving the healthy breast tissue surrounding the tumor. Unfortunately, this is not always possible, and often a great deal of healthy...

Read More